📊 PEPG Key Takeaways
Is PepGen Inc. (PEPG) a Good Investment?
PepGen is a pre-revenue pharmaceutical company burning $81.6M annually with approximately 7-8 months of cash runway remaining, creating critical execution and funding risk. While the 25.6% YoY improvement in losses and strong balance sheet provide some mitigation, the company faces imminent capital requirements without demonstrated product commercialization.
Why Buy PepGen Inc. Stock? PEPG Key Strengths
- Strong balance sheet with $147.4M stockholders' equity and zero long-term debt
- Excellent liquidity position: $60.5M cash with 11.94x current ratio provides near-term stability
- Improving loss trend with 25.6% YoY EPS improvement indicates operational efficiency gains
PEPG Stock Risks: PepGen Inc. Investment Risks
- Pre-revenue status with no commercial product generating income; dependency on single or limited pipeline assets
- Critical cash runway of 7-8 months at current $81.6M annual burn rate; imminent dilution or failure risk without capital raise
- Negative free cash flow of $81.9M with no clear path to profitability; high execution risk tied to clinical trial outcomes and regulatory approvals
Key Metrics to Watch
- Quarterly cash burn rate and remaining runway (watch for acceleration or deceleration)
- Clinical trial progress and FDA milestone achievements (critical for valuation inflection)
- Capital raise announcements or partnership deals (required for survival beyond Q3 2026)
PepGen Inc. (PEPG) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 11.94x current ratio provides a solid financial cushion.
PEPG Profit Margin, ROE & Profitability Analysis
PEPG vs Healthcare Sector: How PepGen Inc. Compares
How PepGen Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is PepGen Inc. Stock Overvalued? PEPG Valuation Analysis 2026
Based on fundamental analysis, PepGen Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
PepGen Inc. Balance Sheet: PEPG Debt, Cash & Liquidity
PEPG Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: PepGen Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-2.85 indicates the company is currently unprofitable.
PEPG Revenue Growth, EPS Growth & YoY Performance
PepGen Inc. Dividends, Buybacks & Capital Allocation
PEPG SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for PepGen Inc. (CIK: 0001835597)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PEPG
What is the AI rating for PEPG?
PepGen Inc. (PEPG) has an AI rating of SELL with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PEPG's key strengths?
Claude: Strong balance sheet with $147.4M stockholders' equity and zero long-term debt. Excellent liquidity position: $60.5M cash with 11.94x current ratio provides near-term stability.
What are the risks of investing in PEPG?
Claude: Pre-revenue status with no commercial product generating income; dependency on single or limited pipeline assets. Critical cash runway of 7-8 months at current $81.6M annual burn rate; imminent dilution or failure risk without capital raise.
What is PEPG's revenue and growth?
PepGen Inc. reported revenue of N/A.
Does PEPG pay dividends?
PepGen Inc. does not currently pay dividends.
Where can I find PEPG SEC filings?
Official SEC filings for PepGen Inc. (CIK: 0001835597) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PEPG's EPS?
PepGen Inc. has a diluted EPS of $-2.12.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PEPG a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, PepGen Inc. has a SELL rating with 72% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PEPG stock overvalued or undervalued?
Valuation metrics for PEPG: ROE of -60.8% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy PEPG stock in 2026?
Our dual AI analysis gives PepGen Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PEPG's free cash flow?
PepGen Inc.'s operating cash flow is $-81.6M, with capital expenditures of $264.0K.
How does PEPG compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -60.8% (avg: 15%), current ratio 11.94 (avg: 2).